Back to search
Anemia (Iron-Loading)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Anemia (Iron-Loading) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Anemia (Iron-Loading) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The prevalence of preoperative anaemia in patients undergoing major surgery is approximately 30%, and is independently associated with higher mortality, a highe…
Genetic disorders, such as thalassemia, can lead to iron overload and severe adverse health outcomes. In iron-loading thalassemia, iron overload is due to incre…
To demonstrate the safety and effectiveness of orally-administered pyridoxal isonicotinoyl hydrazone (PIH) for the chronic treatment of iron overload.
The improved long-term survival of thalassemia major (TM) patients has resulted in increased focus on the ability to preserve fertility. While the association o…
The purpose of this study is to initiate pilot studies to demonstrate that a sufficient number of iron-overloaded thalassemia, SCD and DBA populations with simi…
A long term observational study in sickle cell disease will enhance the understanding of the disease patterns, current transfusion practices, treatments and out…
This study will evaluate the change in cardiac iron load over a 53 week period measured by MRI in 2 cohorts of patients
Iron affects immunity. However, the exact effect of iron on the innate immune response is not known. Animal data suggest that iron administration induced oxidat…
A prospective randomized study on Safety, Tolerability and Efficacy of oral Low dose DFP (50 mg/kg/day) in minimally transfused B-TM after 5 transfusions when S…
To determine whether deferoxamine prevented the complications of transfusional iron overload.
The purpose of this study is to describe alterations of serum ferritin, transferrin saturation, soluble transferrin receptor, % hypochromic erythrocytes, % reti…